These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2106150)

  • 1. Ritanserin, a 5-HT2 receptor antagonist, does not modify ECT-induced prolactin release.
    Papakostas Y; Markianos M; Papadimitriou G; Stefanis C
    Psychopharmacology (Berl); 1990; 100(2):206-8. PubMed ID: 2106150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effect of ritanserin on the 5-hydroxytryptophan-mediated cortisol, ACTH and prolactin secretion in humans.
    Lee MA; Nash JF; Barnes M; Meltzer HY
    Psychopharmacology (Berl); 1991; 103(2):258-64. PubMed ID: 1851310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of serotonin3 receptors in prolactin release induced by electroconvulsive therapy: a study with ondansetron.
    Yatham LN; Zis AP; Lam RW; Srisurapanont M; McGarvey K; Agbayewa O
    Psychiatry Res; 1996 Feb; 60(1):33-9. PubMed ID: 8852866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mediation of ACTH and prolactin responses to 5-HTP by 5-HT2 receptors.
    Gartside SE; Cowen PJ
    Eur J Pharmacol; 1990 Apr; 179(1-2):103-9. PubMed ID: 2163847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of fenfluramine and ritanserin on prolactin response to insulin-induced hypoglycemia in obese patients: evidence for failure of the serotoninergic system.
    Bernini GP; Argenio GF; Vivaldi MS; Del Corso C; Sgrò M; Franchi F; Luisi M
    Horm Res; 1989; 31(3):133-7. PubMed ID: 2501208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of the 5-HT2 receptor in the 5-HT receptor-mediated stimulation of prolactin release.
    Albinsson A; Palazidou E; Stephenson J; Andersson G
    Eur J Pharmacol; 1994 Jan; 251(2-3):157-61. PubMed ID: 8149973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of stimulus intensity on prolactin and cortisol release induced by unilateral electroconvulsive therapy.
    Zis AP; Yatham LN; Lam RW; Clark CM; Srisurapanont M; McGarvey K
    Neuropsychopharmacology; 1996 Sep; 15(3):263-70. PubMed ID: 8873109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of thyrotropin-releasing hormone administration on the electroconvulsive therapy induced prolactin responses and seizure time.
    Papakostas Y; Markianos M; Pehlivanidis A; Papadimitriou GN; Zervas IM; Daras M; Stefanis C
    Biol Psychiatry; 1996 Mar; 39(6):444-7. PubMed ID: 8679790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of various serotonin receptor subtype-selective antagonists alone and on m-chlorophenylpiperazine-induced neuroendocrine changes in rats.
    Aulakh CS; Hill JL; Murphy DL
    J Pharmacol Exp Ther; 1992 Nov; 263(2):588-95. PubMed ID: 1432690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactin and thyrotropin responses to ECT after pindolol administration. A placebo controlled study.
    Papakostas Y; Markianos M; Papadimitriou G; Stefanis N; Lykouras L; Stefanis C
    Eur Neuropsychopharmacol; 1993 Mar; 3(1):75-9. PubMed ID: 8471832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolactin and thyrotropin in serum during electroconvulsive therapy in patients with major depressive illness.
    Apéria B; Thorén M; Wetterberg L
    Acta Psychiatr Scand; 1985 Sep; 72(3):302-8. PubMed ID: 4072731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypersensitivity of 5-HT2 receptors in OCD patients. An increased prolactin response after a challenge with meta-chlorophenylpiperazine and pre-treatment with ritanserin and placebo.
    de Leeuw AS; Westenberg HG
    J Psychiatr Res; 2008 Sep; 42(11):894-901. PubMed ID: 18533183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different serotonin receptors mediate blood pressure, heart rate, plasma catecholamine and prolactin responses to m-chlorophenylpiperazine in conscious rats.
    Bagdy G; Szemeredi K; Kanyicska B; Murphy DL
    J Pharmacol Exp Ther; 1989 Jul; 250(1):72-8. PubMed ID: 2746512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender but not stimulus parameters influence prolactin response to electroconvulsive therapy.
    Motreja S; Subbakrishna DK; Subhash MN; Gangadhar BN; Janakiramaiah N; Parameshwara G
    Psychoneuroendocrinology; 1997 Jul; 22(5):337-48. PubMed ID: 9279939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of chronic ritanserin treatment on sleep and the neuroendocrine response to L-tryptophan.
    Idzikowski C; Cowen PJ; Nutt D; Mills FJ
    Psychopharmacology (Berl); 1987; 93(4):416-20. PubMed ID: 3124174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between prolactin responses to ECT and dopaminergic and serotonergic responsivity in depressed patients.
    Markianos M; Hatzimanolis J; Lykouras L
    Eur Arch Psychiatry Clin Neurosci; 2002 Aug; 252(4):166-71. PubMed ID: 12242577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyrotropin and prolactin responses to ECT in schizophrenia and depression.
    Papakostas Y; Markianos M; Papadimitriou G; Lykouras L; Stefanis C
    Psychiatry Res; 1991 Apr; 37(1):5-10. PubMed ID: 1862162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormonal and temperature responses to flesinoxan in normal volunteers: an antagonist study.
    Pitchot W; Wauthy J; Legros JJ; Ansseau M
    Eur Neuropsychopharmacol; 2004 Mar; 14(2):151-5. PubMed ID: 15013031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ritanserin and serotonergic mechanisms in blood pressure and fluid regulation in sheep.
    Nelson M; Coghlan JP; Denton DA; Tresham JJ; Whitworth JA; Scoggins BA
    Clin Exp Pharmacol Physiol; 1987 Jul; 14(7):555-63. PubMed ID: 3124998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of ritanserin, specific 5HT-2 antagonist, on PRL secretion in normal subjects and in different hyperprolactinaemic conditions.
    Falaschi P; Rosa M; Rocco A; D'Urso R; Proietti A; Melis GB
    Clin Endocrinol (Oxf); 1991 Jun; 34(6):449-53. PubMed ID: 1909607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.